Previous 10 | Next 10 |
Bright Health Group ( NYSE: BHG ) plunged ~15% Tuesday after Goldman Sachs downgraded the health insurer to Sell from Neutral, citing the company's recent decision to exit from the Health Insurance Exchange (HIX). Following the decision to close the HIX business, "we see risks a...
Bright Health Group ( NYSE: BHG ) said it had received a written notice from the New York Stock Exchange that it was not in compliance with the continued listing standard. The average closing price of the company’s stock was less than $1 per share over a consecutive 30 trad...
Bright Health Group, Inc. (“Bright Health Group” or the “Company”) (NYSE: BHG), today announced that on December 6, 2022, the Company received a written notice from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued ...
Original press release issued November 9, 2022 has been replaced with this version to correct a typographical error in the Financial Outlook section. “Adjusted EBITDA for 2022 is expected to be a loss of between $550.0 million and $700.0 million”, a correction from...
NeueHealth and Medical Home Network Partner to Reduce Health Care Disparities through New ACO REACH Model PR Newswire CHICAGO , Nov. 9, 2022 /PRNewswire/ -- NeueHealth Partners Community ACO, a partnership between NeueHealth and Medical Home Network, has ...
Bright Health Group, Inc. (BHG) Q3 2022 Earnings Conference Call November 09, 2022 08:00 AM ET Company Participants Stephen Hagan - Director, IR Mike Mikan - President & CEO Cathy Smith - CFO & CAO Conference Call Participants Nathan Rich - Go...
The following slide deck was published by Bright Health Group, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Bright Health Group, Inc. 2022 Q3 - Results - Earnings Call Presentation
Bright Health Group press release ( NYSE: BHG ): Q3 GAAP EPS of -$0.50 misses by $0.12 . Revenue of $1.63B (+50.9% Y/Y) misses by $190M . Lowering Full Year 2022 Enterprise Medical Cost Ratio guidance range to 90% to 92%. Positively revising Full Year 2022 ...
Revenue of $1.6 billion, up 51.3% from Q3'21, GAAP Net Loss of $259.4 million, Adjusted EBITDA Loss of $82.9 million Q2’22 Enterprise Medical Cost Ratio of 90.6%, a strong improvement from the prior year Lowering Full Year 2022 Enterprise Medical Cost ...
Bright Health Group, Inc. ("Bright Health") (NYSE: BHG) today announced it will report Third Quarter financial results before the financial markets open on Wednesday, November 9, 2022, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-re...
News, Short Squeeze, Breakout and More Instantly...
Bright Health Group Inc. Company Name:
BHG Stock Symbol:
NYSE Market:
The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG) today announced that it has adopted NeueH...
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigati...
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guida...